4th NovAliX Virtual Conference

Biophysics in Drug Discovery

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

 Virtual Event    November 17, 2022

Dear Colleagues from the biophysics and drug discovery community,

I am glad to invite you to join us for a short virtual session on November 17, 2022.

The session will feature two interesting talks from:

  • Dr Marc O'REILLY, VP of Molecular Sciences at Astex Pharmaceuticals, who will talk about the combined use of biophysics and structural biology in a target-centered approach, with a focus on covalent FBDD,

  • Dr Iris ALROY, CSO of Anima Biotech Inc., who will tell us about new modalities (mRNA, tRNA, epitranscriptomics) and how to look at mRNA translation using a phenotypic approach involving AI to identify new targets.

and will take place from 8:00AM to 10:AM (PST) | 11:00AM to 1:00 PM (EST) | 17:00 to 19:00 Central European time (CET). More information on these two talks is available here.

Registration is free of charge and open to any scientist interested in the use of biophysics in drug discovery.
So please save the date, I hope you will join us!

Jean-Paul Renaud
Chairman & Scientific Organiser of the NovAliX Conferences